rs1799987
| Orientation | plus |
| Stabilized | plus |
| Make rs1799987(A;A) |
| Make rs1799987(A;G) |
| Make rs1799987(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 3 |
| Position | 46370444 |
| Gene | CCR5, LOC102724297 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1799987 |
| dbSNP (classic) | rs1799987 |
| ClinGen | rs1799987 |
| ebi | rs1799987 |
| HLI | rs1799987 |
| Exac | rs1799987 |
| Gnomad | rs1799987 |
| Varsome | rs1799987 |
| LitVar | rs1799987 |
| Map | rs1799987 |
| PheGenI | rs1799987 |
| Biobank | rs1799987 |
| 1000 genomes | rs1799987 |
| hgdp | rs1799987 |
| ensembl | rs1799987 |
| geneview | rs1799987 |
| scholar | rs1799987 |
| rs1799987 | |
| pharmgkb | rs1799987 |
| gwascentral | rs1799987 |
| openSNP | rs1799987 |
| 23andMe | rs1799987 |
| SNPshot | rs1799987 |
| SNPdbe | rs1799987 |
| MSV3d | rs1799987 |
| GWAS Ctlg | rs1799987 |
| GMAF | 0.4871 |
| Max Magnitude | 0 |
CCR5 59029G, also known as -2459 [PMID 9742978, PMID 12815099]
[PMID 22146622] Polymorphisms of CCL3L1/CCR5 genes and recurrence of hepatitis B in liver transplant recipients
[PMID 15726497
] Gene-environment interaction effects on the development of immune responses in the 1st year of life.
[PMID 17079285
] Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
[PMID 17672867
] Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.
[PMID 17984846] Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation.
[PMID 18182569
] Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.
[PMID 18633107
] G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes.
[PMID 19131662
] A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.
[PMID 19225544
] Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.
[PMID 19263529
] Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.
[PMID 19330901
] Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study.
[PMID 19559392
] A candidate gene association study of 77 polymorphisms in migraine.
[PMID 20031567
] An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study.
[PMID 20206716
] Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations.
[PMID 20487506
] A whole genome association study of mother-to-child transmission of HIV in Malawi.
[PMID 20552027
] Host and viral genetic correlates of clinical definitions of HIV-1 disease progression.
[PMID 21091093
] Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population.
[PMID 22924548] CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis.
| ClinVar | |
|---|---|
| Risk | rs1799987(G;G) |
| Alt | rs1799987(G;G) |
| Reference | rs1799987(A;A) |
| Significance | Other |
| Disease | Acquired immunodeficiency syndrome CCR5 PROMOTER POLYMORPHISM Human immunodeficiency virus type 1 |
| Variation | info |
| Gene | LOC102724297 CCR5 |
| CLNDBN | Acquired immunodeficiency syndrome, delayed progression to CCR5 PROMOTER POLYMORPHISM Human immunodeficiency virus type 1, susceptibility to |
| Reversed | 0 |
| HGVS | NC_000003.11:g.46411935A>G |
| CLNSRC | OMIM Allelic Variant |
| CLNACC | RCV000008671.2, RCV000008674.2, RCV000008675.4, |
[PMID 29696014
] Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas' Heart Disease: Antagonistic Participation of CCR1+ and CCR5+ Cells in Chronic Chagasic Cardiomyopathy.
